SEOUL, Jun. 27 (Korea Bizwire) – South Korean vaccine developers are leveraging the expertise gained during COVID-19 vaccine development to accelerate the creation of messenger RNA (mRNA) vaccine platforms. This push has gained momentum following the Korea Disease Control and Prevention Agency’s recent emphasis on domestically producing mRNA vaccine platforms capable of developing vaccines within 100-200 [...]
CALGARY, Alberta, June 2 (Korea Bizwire) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its mRNA drug discovery partnership with University Health Network (UHN), ranked first on a list of Canada’s top 40 research hospitals by Research Infosource Inc. and within one of the world’s [...]
SEOUL, Jan. 5 (Korea Bizwire) — Daewoong Pharmaceutical Co., a leading South Korean drugmaker, said Thursday that it has signed a contract with Oncorus Inc., a U.S. biotech company, to cooperate in developing and commercializing messenger RNA (mRNA) drugs for cancer patients. Under the deal, the two companies will conduct joint research on the discovery [...]
SEOUL, Sept. 30 (Korea Bizwire) — South Korea aims to develop at least one homegrown messenger RNA (mRNA) vaccine against the new coronavirus by 2023 as part of efforts to secure a stable supply of vaccines, government officials said Thursday. The goal is part of the country’s ambitious plan to become a global hub for [...]
Heidelberg, Germany, Sept. 13 (Korea Bizwire) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current 100L and 1,000L manufacturing capacities for a variety [...]
SHANGHAI, China, July 20 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has established a joint venture with Immorna, a fast-growing biotechnology company focusing on the process development and optimization of mRNA and delivery [...]
LAUPHEIM, GERMANY and MILFORD, MA, USA, Oct. 12 (Korea Bizwire) – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced an agreement to serve as CDMO partner for BioNTech. As an initial project, Rentschler Biopharma will be responsible for key aspects of cGMP (current good manufacturing practice) drug [...]